
Overview
Feline Cushing's (hyperadrenocorticism or HAC) syndrome is a disorder of excessive cortisol secretion by the adrenal glands.
Pathophysiology
Signalment
Signs
Causes & Risk Factors

Differential Diagnosis
CBC/Biochemistry/Urinalysis
Other Laboratory Tests
Screening Tests
Differentiating Tests
Imaging
Diagnostic Procedures
Sex hormone panels or insulin-like growth factor-1 (IGF-1) obtained to rule-out differentials.


Drug(s)
 -17-hydroxysteroid dehydrogenase, which blocks steroid synthesis. In a majority of cases of FCS with PDH, trilostane reduced clinical signs and improved endocrine test results. Doses up to 60 mg/cat PO q12h have been used.
-17-hydroxysteroid dehydrogenase, which blocks steroid synthesis. In a majority of cases of FCS with PDH, trilostane reduced clinical signs and improved endocrine test results. Doses up to 60 mg/cat PO q12h have been used.

Abbreviations
Author Deirdre Chiaramonte
Consulting Editor Deborah S. Greco
Suggested Reading
, . Hyperadrenocorticism in cats (Cushing's syndrome). In: Canine and Feline Endocrinology and Reproduction, 3rd ed. Philadelphia: Saunders, 2004, pp. 358393.
, , . Trilostane therapy for treatment of spontaneous hyperadrenocorticism in cats: 15 cases (2004-2012). J Vet Intern Med 2013, 27:14711477.